The genetics of sleep disorders

Lancet Neurology

Volumn 1, Issue 4, 2002, Pages 242-250

  Taheri, Shahrad ^a   Mignot, Emmanuel ^a  

^a STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOSOMAL DOMINANT DISORDER; CARDIOVASCULAR DISEASE; CIRCADIAN RHYTHM; DISEASE ASSOCIATION; FAMILIAL DISEASE; GENE IDENTIFICATION; HUMAN; METABOLIC DISORDER; MOLECULAR GENETICS; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; RESPIRATORY TRACT DISEASE; REVIEW; SLEEP APNEA SYNDROME; SLEEP DISORDER; ANIMAL; DISEASE MODEL; DOG; GENETICS; MOUSE; NARCOLEPSY; RESTLESS LEGS SYNDROME;

ANIMALS; CHRONOBIOLOGY DISORDERS; DISEASE MODELS, ANIMAL; DOGS; HUMANS; MICE; NARCOLEPSY; RESTLESS LEGS SYNDROME; SLEEP APNEA, OBSTRUCTIVE; SLEEP DISORDERS;

EID: 0012110908     PISSN: 14744422     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1474-4422(02)00103-5     Document Type: Review

References (143)

1. Carkadon M.A., Dement W.C. Normal human sleep: an overview. Kryeger M., Roth T., Dement W.C. Principles and practice of sleep medicine. 3rd edn. 2000;15-25 WB Saunders, Philadelphia.
2. Kripke D.F., Garfinkel L., Wingard D.L., Klauber M.R., Marler M.R. Mortality associated with sleep duration and insomnia. Arch Gen Psychiatry. 59:2002;131-136.
3. Everson C.A. Functional consequences of sustained sleep deprivation in the rat. Behav Brain Res. 69:1995;43-54.
4. Tononi G., Cirelli C. Modulation of brain gene expression during sleep and wakefulness: a review of recent findings. Neuropsychopharmacology. 25:(suppl.):2001;S28-S35.
5. Parmeggiani P.L. Physiological regulation in sleep. Kryeger M., Roth T., Dement W.C. Principles and practice of sleep medicine. 3rd edn. 2000;169-178 WB Saunders, Philadelphia.
6. Borbely A.A. A two process model of sleep regulation. Hum Neurobiol. 1:1982;195-204.
7. Borbely A.A., Achermann P. Sleep homeostasis and models of sleep regulation. J Biol Rhythms. 14:1999;557-568.
8. Edgar D.M., Dement W.C., Fuller C.A. Effect of SCN lesions on sleep in squirrel monkeys: evidence for opponent processes in sleep-wake regulation. J Neurosci. 13:1993;1065-1079.
9. Dijk D.J., Czeisler C.A. Paradoxical timing of the circadian rhythm of sleep propensity serves to consolidate sleep and wakefulness in humans. Neurosci Lett. 166:1994;63-68.
10. Akerstedt T., Folkard S. Validation of the S and C components of the three-process model of alertness regulation. Sleep. 18:1995;1-6.
11. Reppert S.M., Weaver D.R. Molecular analysis of mammalian circadian rhythms. Annu Rev Physiol. 63:2001;647-676.
12. Wager-Smith K., Kay S.A. Circadian rhythm genetics: from flies to mice to humans. Nat Genet. 26:2000;23-27.
13. Czeisler C.A., Duffy J.F., Shanahan T.L., et al. Stability, precision, and near-24-hour period of the human circadian pacemaker. Science. 284:1999;2177-2181.
14. Roehrs T., Roth T. Hypnotics: efficacy and adverse effects. Kryeger M., Roth T., Dement W.C. Principles and practice of sleep medicine. 3rd edn. 2000;414-418 WB Saunders, Philadelphia.
15. Mukhametov L.M. Unihemispheric slow-wave sleep in the Amazonian dolphin. Inia geoffrensis. Neurosci Lett. 79:1987;128-132.
16. Tobler I. Phylogeny of sleep regulation. Kryeger M., Roth T., Dement W.C. Principles and practice of sleep medicine. 3rd edn. 2000;72-81 WB Saunders, Philadelphia.
17. Steriade M. Corticothalamic resonance, states of vigilance, and mentation. Neuroscience. 101:2000;243-276.
18. Siegel J. Brainstem mechanisms generating REM sleep. Kryeger M., Roth T., Dement W.C. Principles and practice of sleep medicine. 3rd edn:2000;112-133 WB Saunders, Philadelphia.
19. Jones B. Basic mechanisms of sleep-wake states. Kryeger M., Roth T., Dement W.C. Principles and practice of sleep medicine. 3rd edn:2000;134-154 WB Saunders, Philadelphia.
20. Szymusiak R., Steininger T., Alam N., McGinty D. Preoptic area sleep-regulating mechanisms. Arch Ital Biol. 139:2001;77-92.
21. Sherin J.E., Shiromani P.J., Saper C.B. Activation of ventolateral preoptic neurons during sleep. Science. 271:1996;216-219.
22. Gallopin T., Fort P., Eggermann E., et al. Identification of sleep-promoting neurons in vitro. Nature. 404:2000;992-995.
23. Taheri S, Zeitzer JM, Mignot E. The role of hypocretins (orexins) in sleep regulation and narcolepsy. Annu Rev Neurosci (in press).
24. Lin J.S., Sakai K., Jouvet M. Evidence for histaminergic arousal mechanisms in the hypothalamus of cat. Neuropharmacology. 27:1988;111-122.
25. Lin L., Faraco J., Li R., et al. The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene. Cell. 98:1999;365-376.
26. Partinen M., Kaprio J., Koskenvuo M., Putkonen P., Langinvainio H. Genetic and environmental determination of human sleep. Sleep. 6:1983;179-185.
27. Heath A.C., Kendler K.S., Eaves L.J., Martin N.G. Evidence for genetic influences on sleep disturbance and sleep pattern in twins. Sleep. 13:1990;318-335.
28. Linkowski P. EEG sleep patterns in twins. J Sleep Res. 8:(suppl. 1):1999;11-13.
29. van Beijsterveldt C.E., Molenaar P.C., de Geus E.J., Boomsma D.I. Heritability of human brain functioning as assessed by electroencephalography. Am J Hum Genet. 58:1996;562-573.
30. Drennan M.D., Shelby J., Kripke D.F., Keslor J., Gillin J.C. Morningness-eveningness is heritable. Soc Neurosci Abstr. 8:1992;196.
31. Antoch M.P., Song E.J., Chang A.M., et al. Functional identification of the mouse circadian clock gene by transgenic BAC rescue. Cell. 89:1997;655-667.
32. King D.P., Zhao Y., Sangoram A.M., et al. Positional cloning of the mouse circadian clock gene. Cell. 89:1997;641-653.
33. Katzenberg D., Young T., Finn L., et al. A CLOCK polymorphism associated with human diurnal preference. Sleep. 21:1998;569-576.
34. Jones C.R., Campbell S.S., Zone S.E., et al. Familial advanced sleep-phase syndrome: a short-period circadian rhythm variant in humans. Nat Med. 5:1999;1062-1065.
35. Toh K.L., Jones C.R., He Y., et al. An hPER2 phosphorylation site mutation in familial advanced sleep phase syndrome. Science. 291:2001;1040-1043.
36. Zheng B., Larkin D.W., Albrecht U., et al. The mPer2 gene encodes a functional component of the mammalian circadian clock. Nature. 400:1999;169-173.
37. Lowrey P.L., Shimomura K., Antoch M.P., et al. Positional syntenic cloning and functional characterization of the mammalian circadian mutation tau. Science. 288:2000;483-492.
38. Ebisawa T., Uchiyama M., Kajimura N., et al. Association of structural polymorphisms in the human period3 gene with delayed sleep phase syndrome. EMBO Rep. 2:2001;342-364.
39. Mignot E. Genetic and familial aspects of narcolepsy. Neurology. 50:(suppl. 1):1998;S16-22.
40. Okun M.L., Lin L., Pelin Z., Hong S., Mignot E. Clinical aspects of narcolepsy-cataplexy across ethnic groups. Sleep. 25:2002;27-35.
41. Carskadon M.A., Dement W.C., Mitler M.M., Roth T., Westbrook P.R., Keenan S. Guidelines for the multiple sleep latency test (MSLT): a standard measure of sleepiness. Sleep. 9:1986;519-524.
42. Mignot E, Lammers GJ, Ripley B, et al. The role of CSF hypocretin measurement in the diagnosis of narcolepsy and hypersomnia. Arch Neurol (in press).
43. Mignot E., Lin L., Rogers W., et al. Complex HLA-DR and -DQ interactions confer risk of narcolepsy-cataplexy in three ethnic groups. Am J Hum Genet. 68:2001;686-699.
44. Chemelli R.M., Willie J.T., Sinton C.M., et al. Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell. 98:1999;437-451.
45. Nishino S., Ripley B., Overeem S., Lammers G.J., Mignot E. Hypocretin (orexin) deficiency in human narcolepsy. Lancet. 355:2000;39-40.
46. Peyron C., Faraco J., Rogers W., et al. A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nat Med. 6:2000;991-997.
47. Thannickal T.C., Moore R.Y., Nienhuis R., et al. Reduced number of hypocretin neurons in human narcolepsy. Neuron. 27:2000;469-474.
48. Hungs M., Lin L., Okun M., Mignot E. Polymorphisms in the vicinity of the hypocretin/orexin are not associated with human narcolepsy. Neurology. 57:2001;1893-1895.
49. Olafsdottir B.R., Rye D.B., Scammell T.E., Matheson J.K., Stefansson K., Gulcher J.R. Polymorphisms in hypocretin/orexin pathway genes and narcolepsy. Neurology. 57:2001;1896-1899.
50. Dauvilliers Y., Neidhart E., Lecendreux M., Billiard M., Tafti M. MAO-A and COMT polymorphisms and gene effects in narcolepsy. Mol Psychiatry. 6:2001;367-372.
51. Hohjoh H., Terada N., Kawashima M., Honda Y., Tokunaga K. Significant association of the tumor necrosis factor receptor 2 (TNFR2) gene with human narcolepsy. Tissue Antigens. 56:2000;446-448.
52. Vela-Bueno A., Campos Castello J.C., Baos R.J. Hereditary cataplexy-Is it primary cataplexy? Waking Sleeping. 2:1978;125-128.
53. Hartse K.M., Zorick F.J., Sicklesteel J.M., Roth T. Isolated cataplexy: a familial study. Henry Ford Hosp Med J. 36:1988;24-27.
54. Parkes J.D. Genetic factors in human sleep disorders with special reference to Norrie disease, Prader-Willi syndrome and Moebius syndrome. J Sleep Res. 8:(suppl. 1):1999;14-22.
55. Challamel M.J., Mazzola M.E., Nevsimalova S., Cannard C., Louis J., Revol M. Narcolepsy in children. Sleep. 17:(suppl):1994;S17-20.
56. Kandt R.S., Emerson R.G., Singer H.S., Valle D.L., Moser H.W. Cataplexy in variant forms of Niemann-Pick disease. Ann Neurol. 12:1982;284-288.
57. Manni R., Politini L., Nobili L., et al. Hypersomnia in the Prader Willi syndrome: clinical-electrophysiological features and underlying factors. Clin Neurophysiol. 112:2001;800-805.
58. Roth B., Buuhova S., Berkova L. Familial sleep paralysis. Schweiz Arch Neurol Neurochir Psychiatr. 102:1968;321-330.
59. Goode G.B. Sleep paralysis. Arch neurol. 6:1962;228-234.
60. Bell C.C., Dixie-Bell D.D., Thompson B. Further studies on the prevalence of isolated sleep paralysis in black subjects. JAMA. 78:1986;649-659.
61. Hori A, Hirose G. Twin studies on parasomnias. Sleep research: proceedings of the World Federation of Sleep Research Societies, 1995: 324 (24A).
62. Dahlitz M., Parkes J.D. Sleep paralysis. Lancet. 341:1993;406-407.
63. Schenck C.H., Bundlie S.R., Mahowald M.W. Delayed emergence of a parkinsonian disorder in 38% of 29 older men initially diagnosed with idiopathic rapid eye movement sleep behaviour disorder. Neurology. 46:1996;388-393.
64. Schenck C.H., Garcia-Rill E., Segall M., Noreen H., Mahowald M.W. HLA class II genes associated with REM sleep behavior disorder. Neurology. 39:1996;261-263.
65. Allen R.P., Earley C.J. Restless legs syndrome: a review of clinical and pathophysiologic features. J Clin Neurophysiol. 18:2001;128-147.
66. Winkelmann J., Wetter T.C., Collado-Seidel V., et al. Clinical characteristics and frequency of the hereditary restless legs syndrome in a population of 300 patients. Sleep. 23:2000;597-602.
67. Desautels A., Turecki G., Montplaisir J., Sequeira A., Verner A., Rouleau G.A. Identification of a major susceptibility locus for restless legs syndrome on chromosome 12q. Am J Hum Genet. 69:2001;1266-1270.
68. Ondo W.G., Vuong K.D., Wang Q. Restless legs syndrome in monozygotic twins: clinical correlates. Neurology. 55:2000;1404-1406.
69. Desautels A., Turecki G., Montplaisir J., et al. Dopaminergic neurotransmission and restless legs syndrome: a genetic association analysis. Neurology. 57:2001;1304-1306.
70. Binder E.B., Kinkead B., Owens M.J., Nemeroff C.B. Neurotensin and dopamine interactions. Pharmacol Rev. 53:2001;453-486.
71. Guilleminault C., Tilkian A., Dement W.C. The sleep apnea syndromes. Annu Rev Med. 27:1976;467-484.
72. Guilleminault C. Clinical features and evaluation of obstructive sleep apnea. Kryeger M., Roth T., Dement W.C. Principles and practice of sleep medicine. 2nd edn:1994;667-677 WB Saunders, Philadelphia.
73. Peppard P.E., Young T., Palta M., Skatrud J. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med. 342:2000;1378-1384.
74. Newman A.B., Nieto F.J., Guidry U., et al. Relation of sleep-disordered breathing to cardiovascular disease risk factors: the Sleep Heart Health Study. Am J Epidemiol. 154:2001;50-59.
75. Young T., Palta M., Dempsey J., Skatrud J., Weber S., Badr S. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med. 328:1993;1230-1235.
76. Ali N.J., Pitson D.J., Stradling J.R. Snoring, sleep disturbance, and behaviour in 4-5 year olds. Arch Dis Child. 68:1993;360-366.
77. Carmelli D., Bliwise D.L., Swan G.E., Reed T. Genetic factors in self-reported snoring and excessive daytime sleepiness: a twin study. Am J Respir Crit Care Med. 164:2001;949-952.
78. Strohl K.P., Saunders N.A., Feldman N.T., Hallett M. Obstructive sleep apnea in family members. N Engl J Med. 299:1978;969-973.
79. Elliot J. Obstructive sleep apnea in a Georgia family: is it hereditary? JAMA. 240:1978;2611.
80. Adickes E.D., Buehler B.A., Sanger W.G. Familial sleep apnea. Hum Genet. 73:1986;39-43.
81. Oren J., Kelly D.H., Shannon D.C. Familial occurrence of sudden infant death syndrome and apnea of infancy. Pediatrics. 80:1987;355-358.
82. El Bayadi S., Millman R.P., Tishler P.V., et al. A family study of sleep apnea: anatomic and physiologic interactions. Chest. 98:1990;554-559.
83. Guilleminault C., Partinen M., Hollman K., Powell N., Stoohs R. Familial aggregates in obstructive sleep apnea syndrome. Chest. 107:1995;1545-1551.
84. Mathur R., Douglas N.J. Family studies in patients with the sleep apnea-hypopnea syndrome. Ann Intern Med. 122:1995;174-178.
85. Pillar G., Lavie P. Assessment of the role of inheritance in sleep apnea syndrome. Am J Respir Crit Care Med. 151:1995;688-691.
86. Jennum P., Sjol A. Snoring, sleep apnoea and cardiovascular risk factors: the MONICA II study. J Epidemiol. 22:1993;439-444.
87. Redline S., Tishler P.V., Tosteson T.D., et al. The familial aggregation of obstructive sleep apnea. Am J Respir Crit Care Med. 151:1995;682-687.
88. Redline S., Leitner J., Arnold J., Tishler P.V., Altose M.D. Ventilatory control abnormalities in familial sleep apnea. Am J Respir Crit Care Med. 156:1997;155-160.
89. Maes H.H., Neale M.C., Eaves L.J. Genetic and environmental factors in relative body weight and human adiposity. Behav Genet. 27:1997;325-351.
90. Bouchard C. Genetic determinants of regional fat distribution. Hum Reprod. 12:(suppl. 1):1997;1-5.
91. Elmasry A., Lindberg E., Berne C., et al. Sleep-disordered breathing and glucose metabolism in hypertensive men: a population-based study. J Intern Med. 249:2001;153-161.
92. Wilcox I., McNamara S.G., Collins F.L., Grunstein R.R., Sullivan C.E. "Syndrome Z": the interaction of sleep apnea, vascular risk factors and heart disease. Thorax. 53:(suppl. 3):1998;S25-28.
93. Reaven G.M. Diet and syndrome X. Curr Atheroscler Rep. 2:2000;503-507.
94. Spiegel K., Leproult R., Van Cauter E. Impact of sleep debt on metabolic and endocrine function. Lancet. 354:1999;1435-1439.
95. Kawakami Y., Irie T., Kishi F., et al. Familial aggregation of abnormal ventilatory control and pulmonary function in chronic obstructive pulmonary disease. Eur J Respir Dis. 62:1981;56-64.
96. Tishler P.V., Redline S., Ferrette V., Hans M.G., Altose M.D. The association of sudden unexpected infant death with obstructive sleep apnea. Am J Respir Crit Care Med. 153:1996;185-263.
97. Guilleminault C., Pelayo R., Leger D., Philip P. First degree relative of ALTE children. Pediatr Res. 50:2001;14-22.
98. Thomas D.A., Swaminathan S., Beardsmore C.S., et al. Comparison of peripheral chemoreceptor respeonses monozygotic and dizygotic twin infants. Am Rev Respir Dis. 148:1993;1605-1609.
99. Kawakami Y., Yamamoto H., Yoshikawa T., Shida A. Chemical and behavioral control of breathing in adult twins. Am Rev Respir Dis. 129:1984;703-707.
100. Yoshizawa T., Akashiba T., Kurashina K., Otsuka K., Horie T. Genetics and obstructive sleep apnea syndrome: a study of human leukocyte antigen (HLA) typing. Intern Med. 32:1993;94-97.
101. Mignot E., Young T., Lin L., Finn L., Palta M. Reduction of REM sleep latency associated with HLA-DQB1 0602 in normal adults. Lancet. 351:1998;727.
102. Jennum P., Hein H.O., Suadicani P., Sorensen H., Gyntelberg F. Snoring, family history, and genetic markers in men: the Copenhagen Male Study. Chest. 107:1995;1289-1293.
103. Zhang J, Zhao B, Gesongluobu, et al. Angiotensin-converting enzyme gene insertion/deletion (I/D) polymorphism in hypertensive patients with different degrees of obstructive sleep apnea. Hypertens Res 2000; 23: 407-411.
104. Staessen J.A., Wang J.G., Brand E., et al. Effects of three candidate genes on prevalence and incidence of hypertension in a Caucasian population. J Hypertens. 19:2001;1349-1358.
105. Breslow J.L. Genetics of lipoprotein abnormalities associated with coronary artery disease susceptibility. Annu Rev Genet. 34:2000;233-254.
106. Chapman J., Korczyn A.D., Karusis D.M., Michaelson D.M. The effects of APOE genotypes on age at onset and progression of neurodegenerative diseases. Neurology. 57:2001;1482-1485.
107. Bliwise D. Dementia. Kryeger M., Roth T., Dement W.C. Principles and practice of sleep medicine. 3rd edn:2000;1058-1071 WB Saunders, Philadelphia.
108. Saarelainen S., Lehtimaki T., Kallonene E., Laasonein K., Poussa T., Neiminen M.M. No relation between apolipoprotein E alleles and obstructive sleep apnea. Clin Genet. 53:1998;147-148.
109. Kadotani H., Kadotani T., Young T., et al. Association between apolipoprotein E, epsilon4 and sleep-disordered breathing in adults. JAMA. 285:2001;2888-2890.
110. Foley D.J., Masaki K., White L., Redline S. Relationship between lipoprotein E, epsilon 4 and sleep-disordered breathing at different ages. JAMA. 286:2001;1447-1448.
111. Mellinger G.D., Balter M.B., Uhlenhuth E.H. Insomnia and its treatment: prevalence and correlates. Arch Gen Psychiatry. 42:1985;225-232.
112. Ford D.E., Kamerow D.B. Epidemiologic study of sleep disturbances and psychiatric disorders. an opportunity for prevention? JAMA. 262:1989;1479-1484.
113. Bastien C.H., Morin C.M. Familial incidence of insomnia. J Sleep Res. 9:2000;49-54.
114. Lugaresi E., Medori R., Montagna P., et al. Fatal familial insomnia and dysautonomia with selective degeneration of thalamic nuclei. N Engl J Med. 315:1986;997-1003.
115. Parchi P., Petersen R.B., Chen S.G., et al. Molecular pathology of fatal familial insomnia. Brain Pathol. 8:1998;539-548.
116. Lugaresi E., Tobler I., Gambetti P., Montagna P. The pathophysiology of fatal familial insomnia. Brain Pathol. 8:1998;521-526.
117. Collins S., McLean C.A., Masters C.L. Gerstmann-Straussler-Scheinker syndrome, fatal familial insomnia, and kuru: a review of these less common human transmissible spongiform encephalopathies. J Clin Neurosci. 8:2001;387-397.
118. Zerr I., Schulz-Schaeffer W.J., Giese A., et al. Current clinical diagnosis in Creutzfeldt-Jakob disease: identification of uncommon variants. Ann Neurol. 48:2000;323-329.
119. Tobler I., Gaus S.E., Deboer T., et al. Altered circadian activity rhythms and sleep in mice devoid of prion protein. Nature. 380:1996;639-642.
120. Prusiner S.B. Molecular biology of prion diseases. Science. 252:1991;1515-1522.
121. Petersen R.B., Parchi P., Richardson S.L., Urig C.B., Gambetti P. Effect of the D178N mutation and the codon 129 polymorphism on the metabolism of the prion protein. J Biol Chem. 271:1996;12661-12668.
122. Marini G., Imeri L., Mancia M. Changes in sleep-waking cycle induced by lesions of medialis dorsalis thalamic nuclei in the cat. Neurosci Lett. 85:1988;223-227.
123. Keefauver S.P., Guilleminault C. Sleep terrors and sleep walking. Kryeger M., Roth T., Dement W.C. Principles and practice of sleep medicine. 2nd edn:1994;567-573 WB Saunders, Philadelphia.
124. Abe K., Shimakawa M. Genetic and developmental aspects of sleep talking and teeth-grinding. Acta Paedopsychiatr. 33:1966;339.
125. Broughton R.J. Sleep disorders: disorders of arousal? Science. 159:1968;1070-1078.
126. Debray P., Huon H. A propos de trois cas de somnambulisme familial. Ann Méd Interne (Paris). 124:1973;27-29.
127. Hälstrom T. Night terror in adults through three generations. Acta Psychiatr Scand. 48:1972;350.
128. Kales A., Soldatos C.R., Bixler E.O., et al. Hereditary factors in sleepwalking and night terrors. Br J Psychiatr. 137:1980;111-118.
129. Abe K., Amatomi M., Oda N. Sleepwalking and recurrent sleeptalking in children of childhood sleepwalkers. Am J Psychiatr. 14:1984;800-801.
130. Bakwin H. Sleepwalking in twins. Lancet. 2:1970;466-467.
131. Hublin C., Kaprio J., Partinen M., Heikki K., Koskenvuo M. Prevalence and genetics of sleepwalking: a population based twin study. Neurology. 48:1987;177-181.
132. Lecendreux M, Mayer G, Bassetti, Neidhart E, Chappuis R, Tafti M. Genetic susceptibility to sleep walking: a candidate approach. J Sleep Res 2000; 9 (suppl. 1): A227.
133. Scheffer I.E., Bhatia K.P., Lopes-Cendes I., et al. Autosomal dominant nocturnal frontal lobe epilepsy: a distinctive clinical disorder. Brain. 118:1995;61-73.
134. Hayman M., Scheffer I.E., Chinvarun Y., Berlangieri S.U., Berkovic S.F. Autosomal dominant nocturnal frontal lobe epilepsy: demonstration of focal frontal onset and intrafamilial variation. Neurology. 49:1997;969-975.
135. Phillips H.A., Scheffer I.E., Berkovic S.F., Hollway G.E., Sutherland G.R., Mulley J.C. Localization of a gene for autosomal dominant nocturnal frontal lobe epilepsy to chromosome 20q 13.2. Nat Genet. 10:1995;117-118.
136. Steinlein O.K., Mulley J.C., Propping P., et al. A missense mutation in the neuronal nicotinic acetylcholine receptor alpha 4 subunit is associated with autosomal dominant nocturnal frontal lobe epilepsy. Nat Genet. 11:1995;201-203.
137. Weiland S., Witzemann V., Villarroel A., Propping P., Steinlein O. An amino acid exchange in the second transmembrane segment of a neuronal nicotinic receptor causes partial epilepsy by altering its desensitization kinetics. FEBS Lett. 398:1996;91-96.
138. Steinlein O.K., Magnusson A., Stoodt J., et al. An insertion mutation of the CHRNA4 gene in a family with autosomal dominant nocturnal frontal lobe epilepsy. Hum Mol Genet. 6:1997;943-947.
139. Phillips H.A., Scheffer I.E., Crossland K.M., et al. Autosomal dominant nocturnal frontal-lobe epilepsy: genetic heterogeneity and evidence for a second locus at 15q24. Am J Hum Genet. 63:1998;1108-1116.
140. De Fusco M., Becchetti A., Patrignani A., et al. The nicotinic receptor 2 subunit is mutant in nocturnal frontal lobe epilepsy. Nat Genet. 26:2000;275-276.
141. Phillips H.A., Favre I., Kirkpatrick M., et al. CHRNB2 is the second acetylcholine receptor subunit associated with autosomal dominant nocturnal frontal lobe epilepsy. Am J Hum Genet. 68:2001;225-231.
142. Panda S., Hogenesch J.B., Kay S.A. Circadian rhythms from flies to human. Nature. 417:2002;329-335.
143. Mignot E. A commentary on the neurobiology of the hypocretin/orexin system. Neuropsychopharmacology. 25:(suppl):2001;S5-13.